Vironova BioAnalytics AB Acquired by an Investor Syndicate, Led by Quatre Lab, to Expand Its TEM Services for the Pharmaceutical Industry; To Be Rebranded as QuTEM

Vironova BioAnalytics, a leading provider of transmission electron microscopy (TEM) services, is pleased to announce its acquisition led by QuatreLab (a quality control company created by Columbus Venture Partners) with the participation of Accord Investment Partners and Venture Targeter AB. This strategic move will enable Vironova BioAnalytics to enhance its capabilities and continue to deliver TEM analyses according to Good Manufacturing Practices (GMP) for the pharmaceutical industry. Following the completion of the acquisition, the company will be renamed and rebranded as QuTEM.

Read the full article: Vironova BioAnalytics AB Acquired by an Investor Syndicate, Led by Quatre Lab, to Expand Its TEM Services for the Pharmaceutical Industry; To Be Rebranded as QuTEM //

Source: https://www.globenewswire.com/news-release/2023/11/20/2783559/0/en/Vironova-BioAnalytics-AB-Acquired-by-an-investor-syndicate-led-by-Quatre-Lab-to-expand-its-TEM-services-for-the-pharmaceutical-industry-to-be-rebranded-as-QuTEM.html

Leave a Comment

Your email address will not be published.

Scroll to Top